missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DRAK1 Synthetic Peptide
Description
This peptide corresponds to 15 amino amino terminus of human DRAK1. PEP-0051 can be used as a blocking peptide with polyclonal antibody PA5-19926.
STK17A (DRAK1) is a serine/threonine kinase localized in the nucleus and involved in apoptosis. Diseases associated with STK17A include Colon Squamous Cell Carcinoma. Among its related pathways are Sweet Taste Signaling. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is STK17B.
Specifica
Specifica
| Gene ID (Entrez) | 9263 |
| Species | Human |
| Purification Method | purified |
| Accession Number | Q9UEE5 |
| Common Name | DRAK1 |
| Concentration | 200 μg/mL |
| Content And Storage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Vedi altri risultati |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?